Greatmark Investment Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Greatmark Investment Partners's NVS Position: Q2 2021 in Review
Greatmark Investment Partners sold out of Novartis (NVS) in Q2 2021, closing a stake of 19,798 shares — an estimated $1.69M sold.
Greatmark Investment Partners first reported a position in NVS in Q4 2016 and held it in 18 quarters. The position peaked at $1.93M in Q4 2019. 1,119 funds tracked by Wall St. Rank hold NVS as of Q2 2021.
- Greatmark Investment Partners reported no remaining Novartis position as of Q2 2021 after selling out during the quarter.
- Greatmark Investment Partners sold 19,798 Novartis shares in Q2 2021, an estimated $1.69M.
- Greatmark Investment Partners first reported a position in Novartis in Q4 2016 and held it in 18 quarters.
- Greatmark Investment Partners's Novartis position peaked at $1.93M in Q4 2019.
- 1,119 funds tracked by Wall St. Rank held Novartis as of Q2 2021.
Based on Greatmark Investment Partners's 13F filing for Q2 2021, filed 23 Aug 2021.